{"id":2964,"date":"2026-02-02T14:32:00","date_gmt":"2026-02-02T06:32:00","guid":{"rendered":"https:\/\/www.cytopeutics.com\/?p=2964"},"modified":"2026-02-02T21:02:07","modified_gmt":"2026-02-02T13:02:07","slug":"synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem","status":"publish","type":"post","link":"https:\/\/www.cytopeutics.com\/ms\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0","title":{"rendered":"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy."},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Background<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ischemic cardiomyopathy (ICM) is a leading cause of cardiovascular mortality worldwide. It is defined as abnormal enlargement of the left ventricular (LV) cavity with poor LV function due to coronary artery disease. Currently available established treatments are palliative whereby blood supply is recovered to ischemic regions but fails to regenerate heart tissues. Mesenchymal stem cells (MSCs) offer a promising treatment for ICM given their regenerative and multipotent characteristics. This study aims to investigate the effect of MSCs infusion with concurrent revascularization in patients with severe ICM compared to receiving only revascularization procedure or MSCs infusion.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Methods<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Twenty-seven patients with history of anterior myocardial infarction (MI) and baseline left ventricular ejection fraction (LVEF) of less than 35% were recruited into this study. Patients who are eligible for revascularization were grouped into group A (MSCs infusion with concurrent revascularization) or group B (revascularization only) while patients who were not eligible for revascularization were allocated in group C to receive intracoronary MSCs infusion. LV function was measured using echocardiography.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Results<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Patients who received MSCs infusion (either with or without revascularization) demonstrated significant LVEF improvements at 3, 6 and 12 months post-infusion when compared to baseline LVEF within its own group. When comparing the groups, the magnitude of change in LVEF from baseline for third visits i.e., 12 months post-infusion was significant for patients who received MSCs infusion plus concurrent revascularization in comparison to patients who only had the revascularization procedure.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Conclusion<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

MSCs infusion significantly improves LV function in ICM patients. MSCs infusion plus concurrent revascularization procedure worked synergistically to improve cardiac function in patients with severe ICM.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Keywords<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Intracoronary, ischemic cardiomyopathy (ICM), mesenchymal stem cell (MSC), revascularization<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Affiliations\u00a0<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. Cytopeutics, Selangor, Malaysia.<\/span><\/li>
  2. CMH Specialist Hospital, Negeri Sembilan, Malaysia.<\/span><\/li>
  3. Cardiology Unit, Department of Medicine, Universiti Kebangsaan Malaysia MedicalCentre, Kuala Lumpur, Malaysia.<\/span><\/li>
  4. Adventist Heart Centre, Penang Adventist Hospital, Penang, Malaysia.<\/span><\/li>
  5. Cell Therapy Centre, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.<\/span><\/li>
  6. Faculty of Medicine and Health Sciences, Tunku Abdul Rahman University, Selangor, Malaysia.<\/span><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tDownload paper<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tFull paper link<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    Background Ischemic cardiomyopathy (ICM) is a leading cause of cardiovascular mortality worldwide. It is defined as abnormal enlargement of the left ventricular (LV) cavity with poor LV function due to coronary artery disease. Currently available established treatments are palliative whereby blood supply is recovered to ischemic regions but fails to regenerate heart tissues. Mesenchymal stem […]<\/p>\n","protected":false},"author":1,"featured_media":3010,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[37],"tags":[47,48],"class_list":["post-2964","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-heart-attack-heart-failure-lung-disease","tag-heart-attack","tag-heart-failure-lung-disease"],"acf":[],"yoast_head":"\nSynergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy. - Cytopeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0\" \/>\n<meta property=\"og:locale\" content=\"ms_MY\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy. - Cytopeutics\" \/>\n<meta property=\"og:description\" content=\"Background Ischemic cardiomyopathy (ICM) is a leading cause of cardiovascular mortality worldwide. It is defined as abnormal enlargement of the left ventricular (LV) cavity with poor LV function due to coronary artery disease. Currently available established treatments are palliative whereby blood supply is recovered to ischemic regions but fails to regenerate heart tissues. Mesenchymal stem […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0\" \/>\n<meta property=\"og:site_name\" content=\"Cytopeutics\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-02T06:32:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-02T13:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cytopeutics.com\/wp-content\/uploads\/2026\/01\/Paper2-Heart-Disease-2021.jpg.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1754\" \/>\n\t<meta property=\"og:image:height\" content=\"2481\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#\\\/schema\\\/person\\\/72f689cc496b83192f8c287d93a8915f\"},\"headline\":\"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy.\",\"datePublished\":\"2026-02-02T06:32:00+00:00\",\"dateModified\":\"2026-02-02T13:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0\"},\"wordCount\":358,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cytopeutics.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Paper2-Heart-Disease-2021.jpg.webp\",\"keywords\":[\"Heart Attack\",\"Heart Failure & Lung Disease\"],\"articleSection\":[\"Heart Attack, Heart Failure & Lung Disease\"],\"inLanguage\":\"ms-MY\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0\",\"url\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0\",\"name\":\"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy. - Cytopeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cytopeutics.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Paper2-Heart-Disease-2021.jpg.webp\",\"datePublished\":\"2026-02-02T06:32:00+00:00\",\"dateModified\":\"2026-02-02T13:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0#breadcrumb\"},\"inLanguage\":\"ms-MY\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0#primaryimage\",\"url\":\"https:\\\/\\\/www.cytopeutics.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Paper2-Heart-Disease-2021.jpg.webp\",\"contentUrl\":\"https:\\\/\\\/www.cytopeutics.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Paper2-Heart-Disease-2021.jpg.webp\",\"width\":1754,\"height\":2481,\"caption\":\"Paper2-Heart Disease 2021\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/abstracts-publication\\\/heart-attack-heart-failure-lung-disease\\\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\\\/\u00a0#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cytopeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/www.cytopeutics.com\\\/\",\"name\":\"Cytopeutics\",\"description\":\"Pioneering Stem Cell Research & Development\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cytopeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ms-MY\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#organization\",\"name\":\"Cytopeutics\",\"url\":\"https:\\\/\\\/www.cytopeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cytopeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/New-Logo.png.webp\",\"contentUrl\":\"https:\\\/\\\/www.cytopeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/New-Logo.png.webp\",\"width\":600,\"height\":156,\"caption\":\"Cytopeutics\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cytopeutics.com\\\/#\\\/schema\\\/person\\\/72f689cc496b83192f8c287d93a8915f\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/12bc1f46f5b9ae3ebe06ecbc387e5fcdf00b211f24e176b753f22f57a02a307a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/12bc1f46f5b9ae3ebe06ecbc387e5fcdf00b211f24e176b753f22f57a02a307a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/12bc1f46f5b9ae3ebe06ecbc387e5fcdf00b211f24e176b753f22f57a02a307a?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/staging.cytopeutics.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy. - Cytopeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0","og_locale":"ms_MY","og_type":"article","og_title":"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy. - Cytopeutics","og_description":"Background Ischemic cardiomyopathy (ICM) is a leading cause of cardiovascular mortality worldwide. It is defined as abnormal enlargement of the left ventricular (LV) cavity with poor LV function due to coronary artery disease. Currently available established treatments are palliative whereby blood supply is recovered to ischemic regions but fails to regenerate heart tissues. Mesenchymal stem […]","og_url":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0","og_site_name":"Cytopeutics","article_published_time":"2026-02-02T06:32:00+00:00","article_modified_time":"2026-02-02T13:02:07+00:00","og_image":[{"width":1754,"height":2481,"url":"https:\/\/www.cytopeutics.com\/wp-content\/uploads\/2026\/01\/Paper2-Heart-Disease-2021.jpg.webp","type":"image\/webp"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0#article","isPartOf":{"@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0"},"author":{"name":"admin","@id":"https:\/\/www.cytopeutics.com\/#\/schema\/person\/72f689cc496b83192f8c287d93a8915f"},"headline":"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy.","datePublished":"2026-02-02T06:32:00+00:00","dateModified":"2026-02-02T13:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0"},"wordCount":358,"publisher":{"@id":"https:\/\/www.cytopeutics.com\/#organization"},"image":{"@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0#primaryimage"},"thumbnailUrl":"https:\/\/www.cytopeutics.com\/wp-content\/uploads\/2026\/01\/Paper2-Heart-Disease-2021.jpg.webp","keywords":["Heart Attack","Heart Failure & Lung Disease"],"articleSection":["Heart Attack, Heart Failure & Lung Disease"],"inLanguage":"ms-MY"},{"@type":"WebPage","@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0","url":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0","name":"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy. - Cytopeutics","isPartOf":{"@id":"https:\/\/www.cytopeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0#primaryimage"},"image":{"@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0#primaryimage"},"thumbnailUrl":"https:\/\/www.cytopeutics.com\/wp-content\/uploads\/2026\/01\/Paper2-Heart-Disease-2021.jpg.webp","datePublished":"2026-02-02T06:32:00+00:00","dateModified":"2026-02-02T13:02:07+00:00","breadcrumb":{"@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0#breadcrumb"},"inLanguage":"ms-MY","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0"]}]},{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0#primaryimage","url":"https:\/\/www.cytopeutics.com\/wp-content\/uploads\/2026\/01\/Paper2-Heart-Disease-2021.jpg.webp","contentUrl":"https:\/\/www.cytopeutics.com\/wp-content\/uploads\/2026\/01\/Paper2-Heart-Disease-2021.jpg.webp","width":1754,"height":2481,"caption":"Paper2-Heart Disease 2021"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cytopeutics.com\/abstracts-publication\/heart-attack-heart-failure-lung-disease\/synergistic-effects-of-intracoronary-infusion-of-autologous-bone-marrow-derived-mesenchymal-stem-cells-and-revascularization-procedure-on-improvement-of-cardiac-function-in-patients-with-severe-ischem\/\u00a0#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cytopeutics.com\/"},{"@type":"ListItem","position":2,"name":"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy."}]},{"@type":"WebSite","@id":"https:\/\/www.cytopeutics.com\/#website","url":"https:\/\/www.cytopeutics.com\/","name":"Cytopeutics","description":"Pioneering Stem Cell Research & Development","publisher":{"@id":"https:\/\/www.cytopeutics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cytopeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ms-MY"},{"@type":"Organization","@id":"https:\/\/www.cytopeutics.com\/#organization","name":"Cytopeutics","url":"https:\/\/www.cytopeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/www.cytopeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.cytopeutics.com\/wp-content\/uploads\/2025\/09\/New-Logo.png.webp","contentUrl":"https:\/\/www.cytopeutics.com\/wp-content\/uploads\/2025\/09\/New-Logo.png.webp","width":600,"height":156,"caption":"Cytopeutics"},"image":{"@id":"https:\/\/www.cytopeutics.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cytopeutics.com\/#\/schema\/person\/72f689cc496b83192f8c287d93a8915f","name":"admin","image":{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/secure.gravatar.com\/avatar\/12bc1f46f5b9ae3ebe06ecbc387e5fcdf00b211f24e176b753f22f57a02a307a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/12bc1f46f5b9ae3ebe06ecbc387e5fcdf00b211f24e176b753f22f57a02a307a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/12bc1f46f5b9ae3ebe06ecbc387e5fcdf00b211f24e176b753f22f57a02a307a?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/staging.cytopeutics.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/posts\/2964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/comments?post=2964"}],"version-history":[{"count":12,"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/posts\/2964\/revisions"}],"predecessor-version":[{"id":3158,"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/posts\/2964\/revisions\/3158"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/media\/3010"}],"wp:attachment":[{"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/media?parent=2964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/categories?post=2964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cytopeutics.com\/ms\/wp-json\/wp\/v2\/tags?post=2964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}